Kyung-Jae Park
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Kyung-Jae Park has a total of 45 co-authors. Here are the top co-authors by number of shared publications:
Dong-Hyuk Park
Department of Neurosurgery, Korea University Anam Hospital, Korea University College of Medicine, Seoul, South Korea
6 shared publications- Jaemo Park
Pohang University of Science and Technology (POSTECH)
6 shared publications Shin-Hyuk Kang
Department of Neurosurgery, Korea University Anam Hospital, Korea University College of Medicine, Seoul, South Korea
5 shared publications- Shin-Hyuk Kang
Department of Neurosurgery, Korea University Hospital, Korea University College of Medicine, Seoul, Korea
5 shared publications - Chiung Hwang
Department of Physics, POSTECH 790-784 Pohang Korea
4 shared publications - Jang Hun Kim
Department of Neurosurgery Korea University Anam Hospital Korea University College of Medicine Seoul Korea
3 shared publications
Latest Publications
- Open Access
- 18 October 2025
- Published by International Scientific Information, Inc. in Medical Science Monitor
- Vol. 31, e950987
Clinical Outcomes and Prognostic Factors in Cerebral Abscess: Hyperglycemia as a Predictor of the Need for Prolonged Antibiotic Therapy
BACKGROUND The aim of this study was to assess treatment outcomes in patients with cerebral abscess at a single institution based on 2 decades of experience. MATERIAL AND METHODS This study enrolled 112 patients diagnosed with cerebral abscess who underwent image-guided abscess drainage followed by antibiotic therapy between 2003 and 2023. We analyzed the patients' clinical, radiological, and laboratory parameters to identify factors associated with outcomes, as assessed by the Glasgow Outcome Scale (favorable ≥4, unfavorable <4), at discharge. In addition, we evaluated factors affecting the duration of antimicrobial administration. RESULTS Of the 112 cerebral abscess patients, 52 (46%) had predisposing factors, including contiguous or distant infection, a history of neurosurgery, or trauma. Microorganisms were isolated from 56 (50%) patients, with Streptococcus spp. being the most commonly identified (32 patients, 29%). The median duration of antimicrobial treatment was 43 days. At discharge, 87 patients (78%) had favorable outcomes, while 25 (22%) had unfavorable outcomes, including 15 deaths (13%). Poor neurological status (Glasgow Coma Scale score <13) on admission independently predicted unfavorable clinical outcomes (P=0.002). Hyperglycemia at admission was further associated with prolonged antimicrobial therapy (P=0.004), while blood glucose levels were positively correlated with the duration of antimicrobial therapy (r=0.455, P<0.001). CONCLUSIONS This study revealed that the consciousness level upon admission was related to treatment outcomes in patients with cerebral abscess. Hyperglycemia at initial presentation was also identified as an independent predictor of the need for long-term antibiotic use.
- 18 October 2025
- Published by International Scientific Information, Inc. in Medical Science Monitor
- Vol. 31, e950987
Open AccessClinical Outcomes and Prognostic Factors in Cerebral Abscess: Hyperglycemia as a Predictor of the Need for Prolonged Antibiotic Therapy
BACKGROUND The aim of this study was to assess treatment outcomes in patients with cerebral abscess at a single institution based on 2 decades of experience. MATERIAL AND METHODS This study enrolled 112 patients diagnosed with cerebral abscess who underwent image-guided abscess drainage followed by antibiotic therapy between 2003 and 2023. We analyzed the patients' clinical, radiological, and laboratory parameters to identify factors associated with outcomes, as assessed by the Glasgow Outcome Scale (favorable ≥4, unfavorable <4), at discharge. In addition, we evaluated factors affecting the duration of antimicrobial administration. RESULTS Of the 112 cerebral abscess patients, 52 (46%) had predisposing factors, including contiguous or distant infection, a history of neurosurgery, or trauma. Microorganisms were isolated from 56 (50%) patients, with Streptococcus spp. being the most commonly identified (32 patients, 29%). The median duration of antimicrobial treatment was 43 days. At discharge, 87 patients (78%) had favorable outcomes, while 25 (22%) had unfavorable outcomes, including 15 deaths (13%). Poor neurological status (Glasgow Coma Scale score <13) on admission independently predicted unfavorable clinical outcomes (P=0.002). Hyperglycemia at admission was further associated with prolonged antimicrobial therapy (P=0.004), while blood glucose levels were positively correlated with the duration of antimicrobial therapy (r=0.455, P<0.001). CONCLUSIONS This study revealed that the consciousness level upon admission was related to treatment outcomes in patients with cerebral abscess. Hyperglycemia at initial presentation was also identified as an independent predictor of the need for long-term antibiotic use.
- Open Access
- 5 April 2025
- Published by Springer Nature in Scientific Reports
- Vol. 15 (1) , 1-12
Comparative analysis of stereotactic aspiration via supraorbital keyhole versus Kocher’s point for basal ganglia intracerebral hematoma: computational simulation and propensity score-matched study
Catheter placement via the supraorbital keyhole (SOK) for removing spontaneous intracerebral hemorrhage (sICH) in the basal ganglia may result in improved aspiration rates and functional outcomes than those by the conventional Kocher’s point (KP) route. Verification was performed using he results of computational simulations and retrospective clinical data matched by propensity scores. We retrospectively enrolled 50 patients who underwent stereotactic hematoma aspiration of ‘typical’ shape of basal ganglia sICH. After propensity score matching (PSM), comparative analyses between the two groups (n = 36) were performed. A computational simulation of hematoma aspiration was conducted in eight patients using 2-mm thin-sliced brain computed tomography images obtained preoperatively. After PSM, eighteen patients in each group were newly matched and the logit propensity score of the was 0.04 ± 0.0726. The aspiration rate was significantly higher in the SOK group (31.841 ± 40.131 in KP vs. 55.191 ± 25.387 in SOK, p = 0.045), and the proportion of patients who achieved good functional outcomes (mRS score, 0–2 at 6 months) was significantly higher in the SOK group (27.8% vs. 61.1%, p = 0.044). The computational simulations also demonstrated a lower residual volume rate in the SOK group than in the KP group in those with a typical ICH type (21.5% vs. 43.4%). Stereotactic hematoma aspiration via the SOK route in patients with typical basal ganglia ICH is a safe and effective method with an enhanced aspiration rate and favorable functional outcomes.
- 5 April 2025
- Published by Springer Nature in Scientific Reports
- Vol. 15 (1) , 1-12
Open AccessComparative analysis of stereotactic aspiration via supraorbital keyhole versus Kocher’s point for basal ganglia intracerebral hematoma: computational simulation and propensity score-matched study
Catheter placement via the supraorbital keyhole (SOK) for removing spontaneous intracerebral hemorrhage (sICH) in the basal ganglia may result in improved aspiration rates and functional outcomes than those by the conventional Kocher’s point (KP) route. Verification was performed using he results of computational simulations and retrospective clinical data matched by propensity scores. We retrospectively enrolled 50 patients who underwent stereotactic hematoma aspiration of ‘typical’ shape of basal ganglia sICH. After propensity score matching (PSM), comparative analyses between the two groups (n = 36) were performed. A computational simulation of hematoma aspiration was conducted in eight patients using 2-mm thin-sliced brain computed tomography images obtained preoperatively. After PSM, eighteen patients in each group were newly matched and the logit propensity score of the was 0.04 ± 0.0726. The aspiration rate was significantly higher in the SOK group (31.841 ± 40.131 in KP vs. 55.191 ± 25.387 in SOK, p = 0.045), and the proportion of patients who achieved good functional outcomes (mRS score, 0–2 at 6 months) was significantly higher in the SOK group (27.8% vs. 61.1%, p = 0.044). The computational simulations also demonstrated a lower residual volume rate in the SOK group than in the KP group in those with a typical ICH type (21.5% vs. 43.4%). Stereotactic hematoma aspiration via the SOK route in patients with typical basal ganglia ICH is a safe and effective method with an enhanced aspiration rate and favorable functional outcomes.
- Open Access
- 1 January 2025
- Published by XMLink in Journal of Korean Medical Science
- Vol. 40 (28) , e159
Feasibility and Safety of Stereotactic Hematoma Aspiration via Supraorbital Keyhole Route in Patients With Basal Ganglia Spontaneous Intracerebral Hemorrhage: A Single Center Retrospective Analysis
Kim JH, et al. J Korean Med Sci. 2025 May;40:e159. https://doi.org/10.3346/jkms.2025.40.e159
- 1 January 2025
- Published by XMLink in Journal of Korean Medical Science
- Vol. 40 (28) , e159
Open AccessFeasibility and Safety of Stereotactic Hematoma Aspiration via Supraorbital Keyhole Route in Patients With Basal Ganglia Spontaneous Intracerebral Hemorrhage: A Single Center Retrospective Analysis
Kim JH, et al. J Korean Med Sci. 2025 May;40:e159. https://doi.org/10.3346/jkms.2025.40.e159
- Open Access
- 1 January 2024
- Published by XMLink in Brain Tumor Research and Treatment
- Vol. 12 (2) , 115-120
Primary Intracranial Ewing Sarcoma With an Unusual Presentation: A Case Report
Kim HJ, et al. Brain Tumor Res Treat. 2024 Apr;12(2):115-120. https://doi.org/10.14791/btrt.2024.0003
- 1 January 2024
- Published by XMLink in Brain Tumor Research and Treatment
- Vol. 12 (2) , 115-120
Open AccessPrimary Intracranial Ewing Sarcoma With an Unusual Presentation: A Case Report
Kim HJ, et al. Brain Tumor Res Treat. 2024 Apr;12(2):115-120. https://doi.org/10.14791/btrt.2024.0003
- Open Access
- 1 January 2023
- Published by XMLink in Brain Tumor Research and Treatment
- Vol. 11 (4) , 266-270
Recurrence of Rathke’s Cleft Cyst Following Surgery and Histopathological Considerations for Recurrence: A Case Presentation
Recurrence of Rathke’s cleft cysts (RCC) following surgery is not uncommon. We present a 33-year-old male patient with chronic headache and visual disturbances whose MRI showed mostly cystic, suprasellar mass with peripheral enhancement. Endoscopic extended transsphenoidal approach and tumor resection was performed and RCC was pathologically confirmed postoperatively. Early recurrence was first suspected at 3 months following surgery, and his serial MRIs showed a recurred mass without associated clinical symptoms. Upon further histopathological study, extensive squamous metaplasia and high Ki-67 were seen. Also, in this study, we discuss important factors associated with cyst recurrence following surgery.
- 1 January 2023
- Published by XMLink in Brain Tumor Research and Treatment
- Vol. 11 (4) , 266-270
Open AccessRecurrence of Rathke’s Cleft Cyst Following Surgery and Histopathological Considerations for Recurrence: A Case Presentation
Recurrence of Rathke’s cleft cysts (RCC) following surgery is not uncommon. We present a 33-year-old male patient with chronic headache and visual disturbances whose MRI showed mostly cystic, suprasellar mass with peripheral enhancement. Endoscopic extended transsphenoidal approach and tumor resection was performed and RCC was pathologically confirmed postoperatively. Early recurrence was first suspected at 3 months following surgery, and his serial MRIs showed a recurred mass without associated clinical symptoms. Upon further histopathological study, extensive squamous metaplasia and high Ki-67 were seen. Also, in this study, we discuss important factors associated with cyst recurrence following surgery.
- Open Access
Repurposing Penfluridol in Combination with Temozolomide for the Treatment of Glioblastoma
Despite the presence of aggressive treatment strategies, glioblastoma remains intractable, warranting a novel therapeutic modality. An oral antipsychotic agent, penflurido (PFD), used for schizophrenia treatment, has shown an antitumor effect on various types of cancer cells. As glioma sphere-forming cells (GSCs) are known to mediate drug resistance in glioblastoma, and considering that antipsychotics can easily penetrate the blood-brain barrier, we investigated the antitumor effect of PFD on patient-derived GSCs. Using five GSCs, we found that PFD exerts an antiproliferative effect in a time- and dose-dependent manner. At IC50, spheroid size and second-generation spheroid formation were significantly suppressed. Stemness factors, SOX2 and OCT4, were decreased. PFD treatment reduced cancer cell migration and invasion by reducing the Integrin α6 and uPAR levels and suppression of the expression of epithelial-to-mesenchymal transition (EMT) factors, vimentin and Zeb1. GLI1 was found to be involved in PFD-induced EMT inhibition. Furthermore, combinatorial treatment of PFD with temozolomide (TMZ) significantly suppressed tumor growth and prolonged survival in vivo. Immunostaining revealed decreased expression of GLI1, SOX2, and vimentin in the PFD treatment group but not in the TMZ-only treatment group. Therefore, PFD can be effectively repurposed for the treatment of glioblastoma by combining it with TMZ.
Open AccessRepurposing Penfluridol in Combination with Temozolomide for the Treatment of Glioblastoma
Despite the presence of aggressive treatment strategies, glioblastoma remains intractable, warranting a novel therapeutic modality. An oral antipsychotic agent, penflurido (PFD), used for schizophrenia treatment, has shown an antitumor effect on various types of cancer cells. As glioma sphere-forming cells (GSCs) are known to mediate drug resistance in glioblastoma, and considering that antipsychotics can easily penetrate the blood-brain barrier, we investigated the antitumor effect of PFD on patient-derived GSCs. Using five GSCs, we found that PFD exerts an antiproliferative effect in a time- and dose-dependent manner. At IC50, spheroid size and second-generation spheroid formation were significantly suppressed. Stemness factors, SOX2 and OCT4, were decreased. PFD treatment reduced cancer cell migration and invasion by reducing the Integrin α6 and uPAR levels and suppression of the expression of epithelial-to-mesenchymal transition (EMT) factors, vimentin and Zeb1. GLI1 was found to be involved in PFD-induced EMT inhibition. Furthermore, combinatorial treatment of PFD with temozolomide (TMZ) significantly suppressed tumor growth and prolonged survival in vivo. Immunostaining revealed decreased expression of GLI1, SOX2, and vimentin in the PFD treatment group but not in the TMZ-only treatment group. Therefore, PFD can be effectively repurposed for the treatment of glioblastoma by combining it with TMZ.
- 1 July 2017
- Published by Elsevier in World Neurosurgery
- Vol. 103, 953.e13-953.e17
Metastatic Intracerebral Plasmacytoma Treated with Radiation and Thalidomide, Dexamethasone with Cyclophosphamide Chemotherapy
- 1 July 2017
- Published by Elsevier in World Neurosurgery
- Vol. 103, 953.e13-953.e17
Metastatic Intracerebral Plasmacytoma Treated with Radiation and Thalidomide, Dexamethasone with Cyclophosphamide Chemotherapy
- Open Access
- 22 March 2017
- Published by International Scientific Information, Inc. in Medical Science Monitor
- Vol. 23, 1401-1412
Factors Associated with Clinical Outcomes in Patients with Primary Intraventricular Hemorrhage
BACKGROUND:Primary intraventricular hemorrhage (PIVH) is an uncommon type of intracerebral hemorrhage. Owing to its rarity, the clinical and radiological factors affecting outcomes in patients with PIVH have not been widely studied. MATERIAL AND METH...
- 22 March 2017
- Published by International Scientific Information, Inc. in Medical Science Monitor
- Vol. 23, 1401-1412
Open AccessFactors Associated with Clinical Outcomes in Patients with Primary Intraventricular Hemorrhage
BACKGROUND:Primary intraventricular hemorrhage (PIVH) is an uncommon type of intracerebral hemorrhage. Owing to its rarity, the clinical and radiological factors affecting outcomes in patients with PIVH have not been widely studied. MATERIAL AND METH...
- Open Access
- 1 January 2016
- Published by The Korean Brain Tumor Society, The Korean Society for Neuro-Oncology in Brain Tumor Research and Treatment
- Vol. 4 (2) , 145-149
World Health Organization Grade II Oligodendroglioma Occurring after Successful Treatment for Childhood Acute Lymphoblastic Leukemia
When treating childhood acute lymphoblastic leukemia (ALL), secondary neoplasms are a significant long term problem. Radiation is generally accepted to be a major cause of the development of secondary neoplasms. Following treatment for ALL, a variety of secondary tumors, including brain tumors, hematologic malignancies, sarcomas, thyroid cancers, and skin cancers have been reported. However, oligodendroglioma as a secondary neoplasm is extremely rare. Herein we present a case of secondary oligodendroglioma occurring 13 years after the end of ALL treatment.
- 1 January 2016
- Published by The Korean Brain Tumor Society, The Korean Society for Neuro-Oncology in Brain Tumor Research and Treatment
- Vol. 4 (2) , 145-149
Open AccessWorld Health Organization Grade II Oligodendroglioma Occurring after Successful Treatment for Childhood Acute Lymphoblastic Leukemia
When treating childhood acute lymphoblastic leukemia (ALL), secondary neoplasms are a significant long term problem. Radiation is generally accepted to be a major cause of the development of secondary neoplasms. Following treatment for ALL, a variety of secondary tumors, including brain tumors, hematologic malignancies, sarcomas, thyroid cancers, and skin cancers have been reported. However, oligodendroglioma as a secondary neoplasm is extremely rare. Herein we present a case of secondary oligodendroglioma occurring 13 years after the end of ALL treatment.
- Open Access
- 1 January 2014
- Published by Korean Neurosurgical Society in Journal of Korean Neurosurgical Society
- Vol. 56 (2) , 152-156
Intracisternal Cranial Root Accessory Nerve Schwannoma Associated with Recurrent Laryngeal Neuropathy
Intracisternal accessory nerve schwannomas are very rare; only 18 cases have been reported in the literature. In the majority of cases, the tumor origin was the spinal root of the accessory nerve and the tumors usually presented with symptoms and signs of intracranial hypertension, cerebellar ataxia, and myelopathy. Here, we report a unique case of an intracisternal schwannoma arising from the cranial root of the accessory nerve in a 58-year-old woman. The patient presented with the atypical symptom of hoarseness associated with recurrent laryngeal neuropathy which is noted by needle electromyography, and mild hypesthesia on the left side of her body. The tumor was completely removed with sacrifice of the originating nerve rootlet, but no additional neurological deficits. In this report, we describe the anatomical basis for the patient's unusual clinical symptoms and discuss the feasibility and safety of sacrificing the cranial rootlet of the accessory nerve in an effort to achieve total tumor resection. To our knowledge, this is the first case of schwannoma originating from the cranial root of the accessory nerve that has been associated with the symptoms of recurrent laryngeal neuropathy.
- 1 January 2014
- Published by Korean Neurosurgical Society in Journal of Korean Neurosurgical Society
- Vol. 56 (2) , 152-156
Open AccessIntracisternal Cranial Root Accessory Nerve Schwannoma Associated with Recurrent Laryngeal Neuropathy
Intracisternal accessory nerve schwannomas are very rare; only 18 cases have been reported in the literature. In the majority of cases, the tumor origin was the spinal root of the accessory nerve and the tumors usually presented with symptoms and signs of intracranial hypertension, cerebellar ataxia, and myelopathy. Here, we report a unique case of an intracisternal schwannoma arising from the cranial root of the accessory nerve in a 58-year-old woman. The patient presented with the atypical symptom of hoarseness associated with recurrent laryngeal neuropathy which is noted by needle electromyography, and mild hypesthesia on the left side of her body. The tumor was completely removed with sacrifice of the originating nerve rootlet, but no additional neurological deficits. In this report, we describe the anatomical basis for the patient's unusual clinical symptoms and discuss the feasibility and safety of sacrificing the cranial rootlet of the accessory nerve in an effort to achieve total tumor resection. To our knowledge, this is the first case of schwannoma originating from the cranial root of the accessory nerve that has been associated with the symptoms of recurrent laryngeal neuropathy.